When did CONMED CORP (CNMD) report earnings last quarter?
CONMED CORP (CNMD) last reported earnings on 1/28/2026.
CONMED CORP (CNMD) Earnings History & Surprises
NYSE:CNMD • US2074101013
Current stock price
37.08 USD
+0.52 (+1.42%)
At close:
37.08 USD
0 (0%)
After Hours:
CNMD Earnings overview
Past quarterly earnings results for CONMED CORP (CNMD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 28, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.84
- Revenue Estimate
- 316.72M
Last Reported
Most Recent- Release Date
- Jan 28, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.43
- EPS Surprise
- 5.94%
- Revenue Surprise
- -0.25%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.43 | 1.35 | 5.94% | 6.72% | 373.198M | 374.13M | -0.25% | 7.88% |
| Q3 2025 | 1.08 | 1.07 | 0.66% | 2.86% | 337.926M | 341.45M | -1.03% | 6.70% |
| Q2 2025 | 1.15 | 1.15 | 0.37% | 17.35% | 342.345M | 344.93M | -0.75% | 3.09% |
| Q1 2025 | 0.95 | 0.83 | 14.78% | 20.25% | 321.256M | 319.64M | 0.51% | 2.88% |
| Q4 2024 | 1.34 | 1.23 | 9.23% | 26.42% | 345.944M | 347.83M | -0.54% | 5.78% |
| Q3 2024 | 1.05 | 1.01 | 3.60% | 16.67% | 316.701M | 324.49M | -2.40% | 3.98% |
| Q2 2024 | 0.98 | 0.93 | 5.49% | 18.07% | 332.097M | 338.97M | -2.03% | 4.55% |
| Q1 2024 | 0.79 | 0.75 | 4.91% | 19.70% | 312.273M | 312.91M | -0.20% | 5.68% |
| Q4 2023 | 1.06 | 1.13 | -6.38% | 152.38% | 327.045M | 338.84M | -3.48% | 30.35% |
| Q3 2023 | 0.90 | 0.85 | 6.31% | 16.88% | 304.578M | 306.93M | -0.77% | 10.72% |
| Q2 2023 | 0.83 | 0.81 | 2.44% | 9.21% | 317.652M | 312.21M | 1.74% | 14.59% |
| Q1 2023 | 0.66 | 0.61 | 8.18% | -5.71% | 295.5M | 272M | 8.64% | 21.96% |
| Q4 2022 | 0.42 | 0.92 | -54.45% | -60.75% | 250.9M | 308.56M | -18.69% | -8.43% |
| Q3 2022 | 0.77 | 0.77 | 0.39% | -3.75% | 275.1M | 286.45M | -3.96% | 10.57% |
| Q2 2022 | 0.76 | 0.76 | -0.21% | 7.04% | 277.2M | 279.68M | -0.89% | 8.62% |
| Q1 2022 | 0.70 | 0.63 | 11.11% | 11.11% | 242.3M | 240.49M | 0.75% | 4.13% |
| Q4 2021 | 1.07 | 1.05 | 1.93% | 27.38% | 274M | 281.34M | -2.61% | 8.39% |
| Q3 2021 | 0.80 | 0.76 | 4.59% | -9.09% | 248.8M | 260.35M | -4.44% | 4.63% |
| Q2 2021 | 0.71 | 0.63 | 12.27% | 1,114.29% | 255.2M | 253.47M | 0.68% | 61.72% |
| Q1 2021 | 0.63 | 0.45 | 41.44% | 23.53% | 232.7M | 221.22M | 5.19% | 8.74% |
| Q4 2020 | 0.84 | 0.78 | 7.77% | - | 252.8M | 268.19M | -5.74% | - |
| Q3 2020 | 0.88 | 0.23 | 277.85% | - | 237.8M | 210.04M | 13.22% | - |
| Q2 2020 | -0.07 | -0.97 | 92.78% | - | 157.8M | 129.12M | 22.21% | - |
| Q1 2020 | 0.51 | 0.47 | 8.02% | - | 214M | 219.14M | -2.35% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
5.44%
Max EPS beat (4)
14.78%
Min EPS beat (4)
0.37%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-0.38%
Max Revenue beat (4)
0.51%
Min Revenue beat (4)
-1.03%
Analysis
In the last 4 quarters, CNMD has consistently beaten EPS estimates in all releases
CNMD has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CNMD has beaten the EPS estimates by 5.4% on average.
In the last 4 quarters, CNMD reported -0.4% below the revenue estimates on average.
Related analysis
CONMED CORP / CNMD Earnings FAQ
Can you provide information on whether CONMED CORP beat earnings estimates in the last quarter?
CONMED CORP (CNMD) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does CONMED CORP (CNMD) beat earnings estimates?
In the last 4 quarters, CONMED CORP (CNMD) has beaten EPS estimates in 4 out of 4 releases.